Thank you for your interest in the study. Because we have reached our enrollment target, we are no longer accepting new participants for this study.
In this study, we are testing a new online doctor-patient tool for adults with multiple sclerosis (MS) and their MS healthcare providers (e.g., doctors, nurses, physician assistants).
- You may be given access to the new online doctor-patient tool that is being tested for people with MS.
- The doctor-patient tool will ask you questions about how you manage your MS, how MS affects your life, and what matters to you.
- It gives you personalized feedback. It creates a short summary to help you talk with your medical team.
- We will suggest you share that summary with your healthcare provider.
- Participants are limited to people with a relapsing form of MS who have a scheduled appointment within the next 12 weeks with their healthcare provider.
- This includes Relapsing Remitting MS (RRMS or RMS), secondary progressive MS (SPMS) with relapses (also known as “active SPMS”), or Clinically Isolated Syndrome (CIS).
- You will be asked to complete six online surveys over the next 12 to 15 months regarding your MS and use of disease modifying therapies (DMT), if any.
- The initial survey will take about 30 minutes, the remaining surveys will take between 5 and 15 minutes.
- Taking part in this research is voluntary. Whether you take part is up to you. If you don’t take part, it won’t be held against you.
- You can take part now and later drop out, and it won’t be held against you.
- This study is sponsored by Shared Decision Making Resources under a Scientific Research with Agreement EMD Serono, a business of Merck KGaA, Darmstadt, Germany and in partnership with the Multiple Sclerosis Association of America (MSAA).
